Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Left ventricular geometry as a major determinant of left ventricular ejection fraction: physiological considerations and clinical implications.

Triposkiadis F, Giamouzis G, Boudoulas KD, Karagiannis G, Skoularigis J, Boudoulas H, Parissis J.

Eur J Heart Fail. 2018 Mar;20(3):436-444. doi: 10.1002/ejhf.1055. Epub 2017 Nov 6. Review.

2.

Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.

Hensen LCR, Goossens K, Delgado V, Abou R, Rotmans JI, Jukema JW, Bax JJ.

Eur J Heart Fail. 2018 Mar;20(3):560-568. doi: 10.1002/ejhf.1077. Epub 2017 Nov 21.

3.

Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.

Lupón J, Díez-López C, de Antonio M, Domingo M, Zamora E, Moliner P, González B, Santesmases J, Troya MI, Bayés-Genís A.

Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824. Epub 2017 Apr 6.

4.

The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.

Lo CI, Lai YH, Chang SN, Kuo JY, Hsieh YC, Bulwer BE, Hung CL, Yeh HI.

Clin Exp Hypertens. 2017;39(5):473-480. doi: 10.1080/10641963.2016.1273947. Epub 2017 Jun 1.

PMID:
28569600
5.

Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.

Skaf S, Thibault B, Khairy P, O'Meara E, Fortier A, Vakulenko HV, Pitre C, White M, Ducharme A; EARTH Investigators.

Can J Cardiol. 2017 Oct;33(10):1274-1282. doi: 10.1016/j.cjca.2017.07.478. Epub 2017 Jul 31.

PMID:
28941607
6.

Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.

Mitro P, Murin P, Valocik G, Simurda M.

Cardiol J. 2014;21(5):524-31. doi: 10.5603/CJ.a2014.0003. Epub 2014 Feb 14.

PMID:
24526506
7.

Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.

Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ.

Am J Cardiol. 2013 Oct 15;112(8):1158-64. doi: 10.1016/j.amjcard.2013.05.061. Epub 2013 Jun 28.

8.

High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.

Cescau A, Van Aelst LNL, Baudet M, Cohen Solal A, Logeart D.

ESC Heart Fail. 2017 Nov;4(4):686-689. doi: 10.1002/ehf2.12172. Epub 2017 Jul 27.

9.

Myocardial contractile dysfunction associated with increased 3-month and 1-year mortality in hospitalized patients with heart failure and preserved ejection fraction.

Zhong L, Ng KK, Sim LL, Allen JC, Lau YH, Sim DK, Lee RK, Poh KK, Chua TS, Kassab GS, Kwok BW, Tan RS.

Int J Cardiol. 2013 Oct 3;168(3):1975-83. doi: 10.1016/j.ijcard.2012.12.084. Epub 2013 Jan 19.

PMID:
23336957
10.

Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy.

Lancellotti P, Senechal M, Moonen M, Donal E, Magne J, Nellessen E, Attena E, Cosyns B, Melon P, Piérard L.

Eur J Echocardiogr. 2009 Jul;10(5):663-8. doi: 10.1093/ejechocard/jep033. Epub 2009 Apr 7.

11.

Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete?

Bristow MR, Kao DP, Breathett KK, Altman NL, Gorcsan J 3rd, Gill EA, Lowes BD, Gilbert EM, Quaife RA, Mann DL.

JACC Heart Fail. 2017 Nov;5(11):772-781. doi: 10.1016/j.jchf.2017.09.009. Review.

12.

Left ventricular remodeling, mechanics, and tissue characterization in congenital aortic stenosis.

Pacileo G, Calabrò P, Limongelli G, Russo MG, Pisacane C, Sarubbi B, Calabrò R.

J Am Soc Echocardiogr. 2003 Mar;16(3):214-20.

PMID:
12618728
13.

Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.

Bosch L, Lam CSP, Gong L, Chan SP, Sim D, Yeo D, Jaufeerally F, Leong KTG, Ong HY, Ng TP, Richards AM, Arslan F, Ling LH.

Eur J Heart Fail. 2017 Dec;19(12):1664-1671. doi: 10.1002/ejhf.873. Epub 2017 Jun 8.

14.

Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.

van der Bijl P, Khidir M, Leung M, Mertens B, Ajmone Marsan N, Delgado V, Bax JJ.

Eur J Heart Fail. 2017 Sep;19(9):1145-1151. doi: 10.1002/ejhf.769. Epub 2017 Feb 8.

15.

Meta-analysis of Exercise Training on Left Ventricular Ejection Fraction in Heart Failure with Reduced Ejection Fraction: A 10-year Update.

Tucker WJ, Beaudry RI, Liang Y, Clark AM, Tomczak CR, Nelson MD, Ellingsen O, Haykowsky MJ.

Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):163-171. doi: 10.1016/j.pcad.2018.08.006. Epub 2018 Sep 15.

16.

Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ.

Circ Heart Fail. 2014 Mar 1;7(2):288-99. doi: 10.1161/CIRCHEARTFAILURE.113.000854. Epub 2013 Dec 23.

17.

Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

Katsi V, Georgiopoulos G, Laina A, Koutli E, Parissis J, Tsioufis C, Nihoyannopoulos P, Tousoulis D.

Heart Fail Rev. 2017 Nov;22(6):641-655. doi: 10.1007/s10741-017-9624-5. Review.

PMID:
28601914
18.

Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.

Agra Bermejo R, Gonzalez Babarro E, López Canoa JN, Varela Román A, Gómez Otero I, Oro Ayude M, Parada Vazquez P, Gómez Rodríguez I, Díaz Castro O, González Juanatey JR.

Cardiol J. 2018;25(3):353-362. doi: 10.5603/CJ.a2017.0103. Epub 2017 Oct 5.

19.

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.

Atchley AE, Kitzman DW, Whellan DJ, Iskandrian AE, Ellis SJ, Pagnanelli RA, Kao A, Abdul-Nour K, O'Connor CM, Ewald G, Kraus WE, Borges-Neto S; HF-ACTION Investigators.

Am Heart J. 2009 Oct;158(4 Suppl):S53-63. doi: 10.1016/j.ahj.2009.07.009.

20.

Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM.

J Am Coll Cardiol. 2009 Jul 28;54(5):410-8. doi: 10.1016/j.jacc.2009.05.013.

Supplemental Content

Support Center